CBC and CBDV

CBC

The full name of CBC is cannabichromene and is close to the cannabinoid CBD, as it is also derived from CBDA acid that has been heat or light treated.

CBC itself is not intoxicating, and its main role and advantage is to support other cannabinoids. This means that it likes other cannabinoids (especially CBD and THC). Scientists confirm in many examples that adding CBC to other cannabinoid molecules increases their level of effectiveness in combating various diseases, sometimes even multiple times.

Research on CBC itself is still in the very early stages, but several potential applications have already been discovered.

Pain – CBC binds most effectively to the vanilloid receptor 1 (TRPV), which is commonly referred to as the “third cannabinoid receptor” in the endocannabinoid system, and to the ankyrin receptor 1 (TRPA1), both of which modulate our perception of pain. This means that CBC can be used as an effective painkiller without the potentially harmful side effects.

Inflammation – CBC has been shown to be particularly effective in reducing inflammation in conditions such as osteoarthritis. Its effectiveness was even greater when combined with THC. It also has antifungal effects

Skin Issues – Interestingly, its anti-inflammatory properties also extend to its effect on preventing inflammation of the sebaceous glands, which are the main cause of many types of acne. Research on this is ongoing, but scientists believe it will be very effective in treating blemishes and skin problems.

Cancer – CBC has properties that block the growth of cancer cells, making it a potential anti-cancer agent.

CBDV

Otherwise known as cannabidivarin, CBDV is a molecule that, according to recent studies, is almost identical to CBD at the molecular level, but its use is unique in that it may benefit people with neurological disorders. Initial findings suggest that CBDV has great potential as a treatment for epilepsy and similar neurological conditions. It has extraordinary anticonvulsant and antiepileptic properties, and scientists speculate that it may even be used as a supportive treatment for Parkinson's disease, post-traumatic tremors, and other conditions in which seizures are a symptom. Previous studies suggest that it not only shortens the duration of epileptic or convulsive seizures, but may even prevent seizures altogether.

In addition to its powerful anticonvulsant properties, CBDV may also provide relief from nausea and vomiting, particularly when they are a side effect of chemotherapy. It is also being studied as an appetite suppressant and as a potential treatment for symptoms of Crohn’s disease and multiple sclerosis.